Christopher G. Wood

Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

Vitaly Margulis, Shahrokh F. Shariat, Surena F. Matin et al. · Cancer · 2009 · 1.1K citations · Full text

Medicine, Surgery, Urology +13

Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

Jean‐Jacques Patard, Emmanuelle Leray, Nathalie Rioux‐Leclercq et al. · Journal of Clinical Oncology · 2005 · 754 citations

Medicine, Oncology, Urology +13

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

Naomi B. Haas, Judith Manola, Robert G. Uzzo et al. · The Lancet · 2016 · 638 citations

Medicine, Oncology, Pharmacology +14

Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study

Jean‐Jacques Patard, Hyung L. Kim, John S. Lam et al. · Journal of Clinical Oncology · 2004 · 420 citations

Medicine, Oncology, Surgery +17

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

Lijun Zhou, Mingli Sun, Xian Zhang et al. · Oncogene · 2015 · 393 citations

Medicine, Oncology, Pharmacology +12